Our CEO, Dr. Fan was invited to present in SAPA-GP(Sino-American Pharmaceutical Professionals Association - Greater Philadelphia)...

Accutar’s side chain flexible docking platform assisted discovery of bisubstrate inhibitors of Nicotinamide N-Methyltransferase (NNMT)

Dr. Fan, presented Accutar’s proprietary deep neural network framework in AI in drug discovery congress, London

Publication of drug binding pocket side chain prediction by deep neural network